Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

'COMBINE-2': Real-world Evidence for Effectiveness of Two Drug Regimen, Antiretroviral Therapy With Integrase Inhibitors Plus a Reverse Transcriptase Inhibitor

NCT04019873 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT04019873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04019873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
'COMBINE-2': Real-world Evidence for Effectiveness of Two Drug Regimen, Antiretroviral Therapy With Integrase Inhibitors Plus a Reverse Transcriptase Inhibitor
Lead sponsor
ViiV Healthcare
Phase
Observational
Overall status
Completed
Start date
November 18, 2019
Completion date
December 5, 2023
Enrollment
774 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections